Zentalis Pharmaceuticals reports promising results from Phase 1 trial of azenosertib, gemcitabine combo

Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a trailblazer in developing small molecule therapeutics for cancer, has released the final results of its Phase 1 trial combining ... Read More